GBM
Clinical trials for GBM explained in plain language.
Never miss a new study
Get alerted when new GBM trials appear
Sign up with your email to follow new studies for GBM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer, that had come back after standard treatments. The goal was to see if VAL-083 could help patients live longer. However, the trial was stopped early after only 2 people enrolled, so…
Matched conditions: GBM
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Brain cancer drug penetration study halted early
Knowledge-focused TerminatedThis study aimed to see how much of the drug infigratinib gets into brain tumors in people with recurrent high-grade glioma (a type of brain cancer). Only 7 participants were enrolled before the study was stopped. The main goal was to measure drug levels in tumor tissue, blood, a…
Matched conditions: GBM
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC